2023 is shaping up to be a pivotal year for promising biotech startups. While the sector faced multiple waves of layoffs, a silver lining is evident: the growing maturity of AI and genomics technologies is fueling a new wave of startup advances, especially in drug development. Amidst the backdrop of that turbulence, a select group…